Calidi Biotherapeutics, Inc. (CLDI)
NYSEAMERICAN: CLDI · Real-Time Price · USD
0.9980
+0.2980 (42.57%)
At close: Jul 10, 2025, 4:00 PM
0.9449
-0.0531 (-5.32%)
Pre-market: Jul 11, 2025, 6:16 AM EDT
Calidi Biotherapeutics Employees
Calidi Biotherapeutics had 28 employees as of December 31, 2024. The number of employees decreased by 13 or -31.71% compared to the previous year.
Employees
28
Change (1Y)
-13
Growth (1Y)
-31.71%
Revenue / Employee
n/a
Profits / Employee
-$770,536
Market Cap
33.53M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 28 | -13 | -31.71% |
| Dec 31, 2023 | 41 | 3 | 7.89% |
| Dec 31, 2022 | 38 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
CLDI News
- 21 hours ago - Calidi Biotherapeutics Inc. (NYSE American: CLDI) Platform Designed to Transform Landscape of Cancer Treatment - GlobeNewsWire
- 1 day ago - Calidi Biotherapeutics Announces Exercise of Warrants for $4.6 Million of Gross Proceeds - GlobeNewsWire
- 2 days ago - Calidi Biotherapeutics Inc. (NYSE American: CLDI) Developing Precision Genetic Medicine Platform for Cancer Treatment - GlobeNewsWire
- 13 days ago - Calidi Biotherapeutics Announces Shareholder Letter from CEO - GlobeNewsWire
- 7 weeks ago - Innovation In Indexing: Why Passive ETFs Matter - ETF Trends
- 2 months ago - Calidi Biotherapeutics Reports Inducement Grant Under NYSE American LLC Company Guide Section 711 - GlobeNewsWire
- 3 months ago - Global X Offers Precise U.S. Equity Exposure with Launch of Domestic Focused Funds - PRNewsWire
- 3 months ago - Calidi Biotherapeutics Announces Closing of $3.9 Million Registered Direct Offering and Concurrent Private Placement - GlobeNewsWire